BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33401386)

  • 21. Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases.
    Corbett KD; Berger JM
    Annu Rev Biophys Biomol Struct; 2004; 33():95-118. PubMed ID: 15139806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential Paralogous Proteins as Potential Antibiotic Multitargets in Escherichia coli.
    Hardy CD
    Microbiol Spectr; 2022 Dec; 10(6):e0204322. PubMed ID: 36445138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases.
    Schmidt BH; Burgin AB; Deweese JE; Osheroff N; Berger JM
    Nature; 2010 Jun; 465(7298):641-4. PubMed ID: 20485342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium falciparum topoisomerases: Emerging targets for anti-malarial therapy.
    Dar A; Godara P; Prusty D; Bashir M
    Eur J Med Chem; 2024 Feb; 265():116056. PubMed ID: 38171145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA topoisomerase I from mycobacteria--a potential drug target.
    Nagaraja V; Sikder D; Jain P
    Curr Pharm Des; 2002; 8(22):1995-2007. PubMed ID: 12171525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The type IA topoisomerase catalytic cycle: A normal mode analysis and molecular dynamics simulation.
    Xiong B; Burk DL; Shen J; Luo X; Liu H; Shen J; Berghuis AM
    Proteins; 2008 Jun; 71(4):1984-94. PubMed ID: 18186484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
    Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
    Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bacterial type I topoisomerases - biological function and potential use as targets for antibiotic treatments].
    Szafran M; Zakrzewska-CzerwiƄska J; Jakimowicz D
    Postepy Hig Med Dosw (Online); 2013 Mar; 67():130-42. PubMed ID: 23475489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of Type IA Topoisomerases.
    Dasgupta T; Ferdous S; Tse-Dinh YC
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33080770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.
    Hooper DC
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S54-63. PubMed ID: 9710672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases.
    Liu Q; Wang JC
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):881-6. PubMed ID: 9927662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demystifying the potential of inhibitors targeting DNA topoisomerases in unicellular protozoan parasites.
    Lamba S; Roy A
    Drug Discov Today; 2023 Jun; 28(6):103574. PubMed ID: 37003515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.
    Yu X; Zhang M; Annamalai T; Bansod P; Narula G; Tse-Dinh YC; Sun D
    Eur J Med Chem; 2017 Jan; 125():515-527. PubMed ID: 27689733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugging topoisomerases: lessons and challenges.
    Pommier Y
    ACS Chem Biol; 2013 Jan; 8(1):82-95. PubMed ID: 23259582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicase-appended topoisomerases: new insight into the mechanism of directional strand transfer.
    Plank J; Hsieh TS
    J Biol Chem; 2009 Nov; 284(45):30737-41. PubMed ID: 19726668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA topoisomerase I and II as targets for rational design of new anticancer drugs.
    Cummings J; Smyth JF
    Ann Oncol; 1993 Aug; 4(7):533-43. PubMed ID: 8395870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA topoisomerase I and DNA gyrase as targets for TB therapy.
    Nagaraja V; Godbole AA; Henderson SR; Maxwell A
    Drug Discov Today; 2017 Mar; 22(3):510-518. PubMed ID: 27856347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topoisomerase Assays.
    Nitiss JL; Kiianitsa K; Sun Y; Nitiss KC; Maizels N
    Curr Protoc; 2021 Oct; 1(10):e250. PubMed ID: 34606690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial topoisomerase I as a target for discovery of antibacterial compounds.
    Tse-Dinh YC
    Nucleic Acids Res; 2009 Feb; 37(3):731-7. PubMed ID: 19042977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA topoisomerases: structure, function, and mechanism.
    Champoux JJ
    Annu Rev Biochem; 2001; 70():369-413. PubMed ID: 11395412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.